Impact of Levofloxacin on Clinical Outcomes 🧒🏼💊

Created using ChatSlide

This presentation explores the impact of Levofloxacin on clinical outcomes in children, particularly within the context of MDR-TB prevention. Conducted through the TB-CHAMP trial, the study assesses the antibiotic's safety, growth effects, and infection rates over a 24-week period among South African children under five. Findings indicate improved haemoglobin levels, reduced infections, and no adverse growth effects, suggesting potential ancillary benefits beyond tuberculosis control. This...